| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/23/2005 | CA2552435A1 Inhibitors of type 2 vascular endothelial growth factor receptors |
| 06/23/2005 | CA2549710A1 Polynucleotides and polypeptides isolated from lactobacillus rhamnosus hn001 materials incorporating them and methods for using them |
| 06/23/2005 | CA2549482A1 Megsin/rage/inos overexpressing renaldisease model animals and methods for evaluating compounds using the model animals |
| 06/23/2005 | CA2549291A1 Use of enzymatic inhibitors of h-prune for the prevention and treatment of the metastases of tumours overexpressing h-prune |
| 06/23/2005 | CA2549164A1 Self-assembling peptide amphiphiles and related methods for growth factor delivery |
| 06/23/2005 | CA2549104A1 Influenza immunogen and vaccine |
| 06/23/2005 | CA2548901A1 Use of goat blood serum derived antibodies obtained after challenge with hiv lysate for veterinary treatment |
| 06/23/2005 | CA2548812A1 Detection of conformationally altered proteins and prions |
| 06/23/2005 | CA2548750A1 Lawsonia intracellularis 26 kd subunit vaccine |
| 06/23/2005 | CA2547877A1 Improved cytokine design |
| 06/23/2005 | CA2547631A1 Methods for treating inflammation using thyroid stimulating hormone |
| 06/23/2005 | CA2547626A1 Tumour suppressor protein |
| 06/23/2005 | CA2547621A1 Transdermal system for sustained delivery of polypeptides |
| 06/23/2005 | CA2547569A1 Recombinant factor viii having increased specific activity |
| 06/23/2005 | CA2546769A1 Production of diphtheria toxin |
| 06/23/2005 | CA2546126A1 Use of t-cadherin as a target |
| 06/23/2005 | CA2543257A1 Methods and compositions for delivering polynucleotides |
| 06/22/2005 | EP1544617A2 Use of a Nifie 14 binding substance for the diagnosis and treatment of cancer |
| 06/22/2005 | EP1544307A1 LAC9 chimeric receptor and uses thereof |
| 06/22/2005 | EP1544301A1 DNA molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP1544299A1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 06/22/2005 | EP1544298A1 Cultured xenopus laevis cell lines expressing mutant adenomatous polyposis coli gene |
| 06/22/2005 | EP1544212A1 Modified antiviral proteins with an increased negative charge |
| 06/22/2005 | EP1544211A1 LSA-5 pre-erythrocytic stage antigen of plasmodium falciparum, immunogenic composition comprising said antigen, and vaccines against malaria |
| 06/22/2005 | EP1544210A1 Novel notch-origin polypeptides and biomarkers and reagents using the same |
| 06/22/2005 | EP1544209A1 Refolded membrane protein in monodisperse form |
| 06/22/2005 | EP1543838A1 Feline infectious peritonitis vaccine |
| 06/22/2005 | EP1543837A1 Virus-like particle (VLP) as vaccine |
| 06/22/2005 | EP1543836A1 Recombinant Vibrio cholerae strain and vaccine comprising said strain |
| 06/22/2005 | EP1543730A1 Cross-linking process of proteins with a ketose containing 3 to 5 carbon atoms |
| 06/22/2005 | EP1543332A2 Protein arrays and uses thereof |
| 06/22/2005 | EP1543329A2 Cell-based fluorescence resonance energy transfer (fret) assays for clostridial toxins |
| 06/22/2005 | EP1543325A2 Flea and tick octopamine receptor nucleic acid molecules, proteins and thereof |
| 06/22/2005 | EP1543165A2 Assays for assembly of ebola virus nucleocapsids |
| 06/22/2005 | EP1543161A2 Methods of identifying compounds that modulate il-4 receptor-mediated ige synthesis utilizing a c-myc protein |
| 06/22/2005 | EP1543156A2 Detection of chemical ligation using fluorescence quenching leaving groups |
| 06/22/2005 | EP1543150A2 Pna probes, probe sets, method and kits pertaining to the determination of listeria |
| 06/22/2005 | EP1543145A2 Antifungal therapeutic targets |
| 06/22/2005 | EP1543122A2 Bitter taste receptors |
| 06/22/2005 | EP1543121A1 Method for designing peptides |
| 06/22/2005 | EP1543120A2 Novel proteins and their uses |
| 06/22/2005 | EP1543113A1 Chicken astrovirus type 2 |
| 06/22/2005 | EP1543112A1 Regulating beta-catenin levels |
| 06/22/2005 | EP1543109A2 Substances for preventing and treating autoimmune diseases |
| 06/22/2005 | EP1543037A2 Dendritic cell pontentiation |
| 06/22/2005 | EP1543032A2 Method for the rational mutagenesis of a/beta t cell receptors and correspondingly mutated mdm2 protein-specific a/beta t-cell receptors |
| 06/22/2005 | EP1543031A1 Monomeric insulin |
| 06/22/2005 | EP1543030A2 Modified glp-1 peptides with increased biological potency |
| 06/22/2005 | EP1543029A1 Interferon-alpha induced gene |
| 06/22/2005 | EP1543028A2 Live antenuated parasite vaccine |
| 06/22/2005 | EP1543027A1 Process for production of cephalosporin c |
| 06/22/2005 | EP1543026A1 Transcriptional activator gene for genes involved in cobalamin biosynthesis |
| 06/22/2005 | EP1543025A2 Human g protein-coupled receptor and modulators thereof for the treatment of ischemic heart disease and congestive heart failure |
| 06/22/2005 | EP1543022A2 Gd2 ligands |
| 06/22/2005 | EP1543020A2 Codon optimized synthetic plasmids |
| 06/22/2005 | EP1543018A1 Gene families associated with liver cancer |
| 06/22/2005 | EP1542722A2 Methods and reagents relating to inflammation and apoptosis |
| 06/22/2005 | EP1542718A2 Peptide derivative fusion inhibitors of hiv infection |
| 06/22/2005 | EP1542716A1 Growth hormone releasing peptides |
| 06/22/2005 | EP1542714A1 Methods of increasing platelet and hematopoietic stem cell production |
| 06/22/2005 | EP1542712A2 Glp-1 formulations with protracted time action |
| 06/22/2005 | EP1542711A2 PEPTIDES AS SOLUBILIZING EXCIPIENTS FOR TRANSFORMING GROWTH FACTOR s PROTEINS |
| 06/22/2005 | EP1542710A1 Methods for preserving organs and tissues |
| 06/22/2005 | EP1542707A2 Compositions and methods for ligament growth and repair |
| 06/22/2005 | EP1542690A2 Manzamine-producing actinomycetes |
| 06/22/2005 | EP1542538A2 Lipase inhibitors and uses thereof |
| 06/22/2005 | EP1542528A1 A method of treatment and prophylaxis |
| 06/22/2005 | EP1485461A4 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 06/22/2005 | EP1483408A4 Nanostructures containing pna joining or functional elements |
| 06/22/2005 | EP1414299A4 Substantially homogeneous bio-affecting material having a pre-determined ratio of bioaffecting component to cell targeting component, the method for making such a material and the method of its use |
| 06/22/2005 | EP1393039A4 Mutation induced optimization of receptor signal to noise ratio |
| 06/22/2005 | EP1244693B1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis |
| 06/22/2005 | EP1196188B1 Vgf selective monoclonal antibodies and their use for treating vgf-related disorders |
| 06/22/2005 | EP1124849B1 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 06/22/2005 | EP1073676B1 Immunodiagnostic reagent for the detection of maedi-visna virus and caev infection |
| 06/22/2005 | EP1073465B1 T cell inhibitory receptor compositions and uses thereof |
| 06/22/2005 | EP0927254B1 Antagonists of interleukin-15 |
| 06/22/2005 | EP0892644B1 In vivo gene transfer methods for wound healing |
| 06/22/2005 | EP0812917B1 Cold-inducible promoter sequences |
| 06/22/2005 | EP0791066B1 Dna molecules that code for enzymes involved in starch synthesis, vectors, bacteria, transgenic plant cells and plants containing said molecules |
| 06/22/2005 | EP0758397B1 Recombinant poxviruses with foreign polynucleotides in essential regions |
| 06/22/2005 | CN1630731A Methods to identify evolutionarily significant changes in polynucleotide and polypeptide sequences in domesticated plants and animals |
| 06/22/2005 | CN1630725A Ethylene-responsive transcription coactivators in plant |
| 06/22/2005 | CN1630722A Adapter-directed display systems |
| 06/22/2005 | CN1630721A Factor VII polypeptides for preventing formation of inhibitors in subjects with haemophilia |
| 06/22/2005 | CN1630720A Bifunctional fusion proteins with glucocerebrosidase activity |
| 06/22/2005 | CN1630709A Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 06/22/2005 | CN1630708A Osteoclast-associated receptor |
| 06/22/2005 | CN1630666A Factor VIII2 C2 domain variants |
| 06/22/2005 | CN1630665A Anti-A beta antibodies and their use |
| 06/22/2005 | CN1630664A Caspase-8 binding protein, its preparation and use |
| 06/22/2005 | CN1630663A Synthetic or natural peptides binding protein phosphatase 2A, identification method and uses |
| 06/22/2005 | CN1630662A Rabbit hemorrhagic disease vaccine and antigens |
| 06/22/2005 | CN1630529A B-cell lymphoma specific antigen for use in diagnosis and treatment of B-cell malignancies |
| 06/22/2005 | CN1629293A A rice blast resistance gene, its encoded protein and use thereof |
| 06/22/2005 | CN1629291A A shrimp gene Intlp and polypeptides coded thereby |
| 06/22/2005 | CN1629194A Super antigen fusion protein for cancer therapy and its producing method |
| 06/22/2005 | CN1629192A Method for modifying freshwater fish skin collagen by using carbohydrate |
| 06/22/2005 | CN1629191A Method for modifying freshwater fish skin collagen by adjusting alkalinity acidity |
| 06/22/2005 | CN1629190A A protein, gene and pharmaceutical use thereof |